Bioinformatics Analyses


Prioritize Biomarkers to Explore in Clinical Development

Champions Oncology excels at high throughput, cost-effective PDX screens.  Performing gene differential analysis, global mutational analysis and pathway mapping, our bioinformatics staff team can help identify biomarkers of response and or resistance.   

More than 80% of the models in the Champions Oncology TumorGraft database are available for these types of studies.

Models can be selected based on tumor type, or on a targeted molecular anomaly, or both to make faster go/no-go decision on the clinical advancement of agents.

Contact us to learn more about Champions Oncology bioinformatics capabilities for biomarker screening.